Place Your Advertisement Here. All ad revenues support the mission of the Epilepsy Therapy Project.
 
Thu, 2/9/2012

Welcome to the redesigned epilepsy.com

It is now easier and faster than ever to access news, articles and community content. With less clutter and an improved navigation system, your favorite content is now only a click away.

The new features include:

  • Streamlined design with less clutter to promote important content and sections
  • New slider masthead
  • New horizontal menu across the site to ease top level navigation
  • Re-designed content pages that are easier to navigate
  • Overall new, fresh look!

Place Your Advertisement Here

Take control of your epilepsy and seizures. Seizure management has never been easier.

TAKE CONTROL TODAY

Sign up for our Newsletter!



You need to upgrade or install Flash to view this content

2012 Epilepsy Pipeline Update Conference


3rd Biennial Conference Networking Forum and
the 1st ETP Family Day!
February 2 – 4, 2012 | Hyatt Regency | San Francisco, CA

REGISTER TODAY

Join us for our 3rd biennial showcase of emerging and established companies presenting their strategies, candidates and development programs. You'll learn how anti-seizure product development is the optimal pathway for CNS therapeutic development because of well-characterized mechanisms, therapeutic approaches, clear clinical endpoints for regulatory studies.

You will be among small, mid, and major CNS companies who present their strategies, product candidates and development programs to potential venture capital, private equity, pharma and biotech investors and partners. Past conferences have included: Cyberonics, Eisai, Lundbeck, Medtronic, Pfizer, Sunovion, SK Lifesciences, Valeant Pharmaceuticals and UCB, as well as private companies such as Advanced NeuroMetrics, Asklepios Biopharmaceuticals, Catalyst Pharma, Marinus Pharmaceuticals, MedGenesis Therapeutix, Medkura, NeuroGenomX, NeuroPace, NeuroTherapeutics, NeuroVista, Supernus Pharmaceuticals, and Visualase.


The Epilepsy Therapy Project is a 501 (c) (3) not-for-profit corporation dedicated to a singular focus: overcoming the funding gaps and roadblocks that slow the progress of new therapies from the lab to the patient. Epilepsy Therapy Project seeks to improve incentives and encourage commercial investment in new therapies. Acting as both a catalyst and clearing house for innovative research and the early commercialization of new therapies, the Epilepsy Therapy Project brings together financial resources, scientific insights and business expertise from leading academic and commercial industry participants.

Epilepsy Therapy Project has raised more than $6 million towards its mission.


Our History

The story of the Epilepsy Therapy Project, its founding in 2002 by parents of young children living with severe epilepsy, and the programs and therapies we have supported. Read more

Our Mission

Learn about the Epilepsy Therapy Project's mission, and why we need your help. Read more

Who We Are

To invest your contributions effectively, we have assembled an outstanding staff and team of clinicians, researchers, and pharmaceutical, biotechnology, and finance industry advisors. These scientific and business advisory board members make funding decisions and provide support to advance the most promising new therapy projects. Meet our team

epilepsy.com

Epilepsy.com is a dynamic online resource providing in-depth information and community for people living with epilepsy, and is the home of the Epilepsy Therapy Project. The mission of epilepsy.com is to inform and empower patients and families facing newly diagnosed epilepsy or those struggling with epilepsy that has resisted treatment. Read more

epilepsy.com professionals

An online resource for healthcare professionals to learn about epilepsy and seizures, co-existing disorders, specialized populations, and diagnosis and treatment for epilepsy. Visit our site for daily research and medical news about epilepsy, commentary from leading voices in the field, and opinions on controversial topics surrounding epilepsy research and treatment. Read more

A Message from Our Chairman and Co-Founder

Keeping a promise, and with thanks and appreciation, Warren Lammert, Chairman and Co-Founder offers some highlights of the Epilepsy Therapy Project's important accomplishments and progress. Read more

Annual Report

Reflecting on the year behind us, this report features some of the programs that are supported through your contributions. Read more


The Epilepsy Therapy Project supports innovative research in both academic and industry settings through direct grants and investments. Learn about our programs and how the Epilepsy Therapy Project is supporting research and helping to advance new therapies.

New Therapy - Commercialization Grants / Apply for Grant Funding

The New Therapy - Commercialization Grants Program is a unique partnership between two leading epilepsy non-profit organizations, the Epilepsy Therapy Project and the Epilepsy Foundation. The mission of the New Therapy - Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source. Read more

Funding Portfolio

The Epilepsy Therapy Project directly supports promising new therapies and emerging epilepsy focused companies through research awards and equity investments. Review the list of funded projects and investments in this section. Read more

Other Sources of Funding

View the list of additional funding sources here. Read more


Jan 30, 2012
Search this Site
Jan 11, 2012
Press Release
Dec 06, 2011
Epilepsy 101
Nov 28, 2011
Sponsored by
Nov 16, 2011
Celebrating life
Nov 16, 2011
EPILEPSY
Nov 01, 2011
Press Release
Aug 25, 2011
Epilepsy factfile

Learn more about the Epilepsy Therapy Project's upcoming events!

Epilepsy Therapy Project's past events


make a donation
Founder's Story in PharmVOICE.com

Warren Lammert in PharmaVOICE.comIn its February issue, PharmaVoice highlights the story of ETP Founder and Chair, Warren Lammert and his daughter, Sylvie, who has uncontrolled seizures. Sylvie inspired Warren, Sylvie’s mother Kathy, and colleagues to initiate the Epilepsy Therapy Project, to accelerate development of new therapies for epilepsy. Read the story

etp logo

Start Your Own Epilepsy Group
Get connected and stay connected! Create a virtual meeting place for your organization or an existing epilepsy research group and deepen your connections using the Group Event Calender, Group Discussions and Shared Member Blogs.

Learn More